Statements of operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 14,110	$ 7,486
General and administrative	11,094	4,775
Total operating expenses	25,204	12,261
Loss from operations	(25,204)	(12,261)
Other income (expenses):
Change in fair value of warrant liability		(5,538)
Other income	503
Interest expense, net	(10)	(38)
Total other expenses	493	(5,576)
Net loss	$ (24,711)	$ (17,837)
Per share information:
Net loss per share of common stock, Basic	$ (2.14)	$ (5.26)
Net loss per share of common stock, Diluted	$ (2.14)	$ (5.26)
Weighted average shares of common stock outstanding, Basic	11,538,668	3,389,592
Weighted average shares of common stock outstanding, Diluted	11,538,668	3,389,592